Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats

被引:7
|
作者
Xing-Guo Tan and Zhu-Lin Yang Research Laboratory of Hepatobiliary Diseases
机构
关键词
pancreatic neoplasms; animal model; Ezrin; hepatocyte growth factor; C-met;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND:Recent studies have confirmed that the expression of Ezrin,hepatocyte growth factor(HGF)and its receptor(C-met)is related to the genesis,progress,invasion and metastasis of some malignant tumors.Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors.However,there is no report on the expression levels of Ezrin,HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA).This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues,and assess its effect in cancer induction by DMBA. METHODS:Ninety Sprague-Dawley rats were divided into 3 groups randomly:40 in a pancreatic cancer model group (group A),40 in a trichostatin A(TSA)intervention group (group B),and 10 in a control group(group C).DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B.The rats of group B were treated with 1 ml of TSA saline solution(1μg/ml)via intraperitoneal injection weekly.The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile,the rats in group C were executed within 5 months. The EnVision TM immunohistochemistry for detecting the expression levels of Ezrin,HGF and C-met was used in paraffinembedded sections of the pancreatic specimens. RESULTS:The incidence of pancreatic cancer in group A was 48.6%and in group B 33.3%.The maximal diameter of tumor mass was significantly larger in group A than that in group B(P<0.05).No pathological changes were observed , in the pancreas of group C and other main organs of groups A and B.The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma than in non- cancerous pancreatic tissues of groups A and B(P<0.01).The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non- cancerous pancreatic tissues of group A(P<0.05),but there was no significant difference in group B(P>0.05).The positive rates of Ezrin,HGF and C-met in non-cancerous pancreatic tissues proved mild to severe atypical hyperplasia of the ductal epithelia.The pancreas of group C and 2 cases of fibrosarcoma showed the negative expression of Ezrin,HGF and C-met.There was a trend of consistency in the expression of Ezrin,HGF and C-met in ductal adenocarcinoma(P<0.05 or P<0.01). CONCLUSIONS:DMBA directly implanted into the parenchyma of the pancreas can produce a model of pancreatic cancer with a high incidence in a short time.TSA might inhibit the carcinogenesis and growth of pancreatic cancer,and its effects may be related to the inhibition of the expression of Ezrin,HGF and C-met during the process.Ezrin,HGF and C-met may have positive effects on the carcinogenesis of rat pancreas.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [31] Current advances of targeting HGF/c-Met pathway in gastric cancer
    Anestis, Aristomenis
    Zoi, Ilianna
    Karamouzis, Michalis V.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (12)
  • [32] HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
    Shao, Zhiwei
    Pan, Haoqi
    Tu, Sheng
    Zhang, Jingying
    Yan, Sheng
    Shao, Anwen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [33] Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
    Kim, Hyun Jung
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [34] HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine
    Yap, Timothy A.
    Sandhu, Shahneen K.
    Alam, Salma M.
    de Bono, Johann S.
    CURRENT DRUG TARGETS, 2011, 12 (14) : 2045 - 2058
  • [35] Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer
    Miranda, Oshin
    Farooqui, Mariya
    Siegfried, Jill M.
    CANCERS, 2018, 10 (09)
  • [36] Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer
    Yan, Hong Hua
    Jung, Kyung Hee
    Son, Mi Kwon
    Fang, Zhenghuan
    Kim, Soo Jung
    Ryu, Ye-Lim
    Kim, Juyoung
    Kim, Mi-Hyun
    Hong, Soon-Sun
    ONCOTARGET, 2014, 5 (19) : 9150 - 9168
  • [37] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
    Liang, Hongge
    Wang, Mengzhao
    ONCOTARGETS AND THERAPY, 2020, 13 : 2491 - 2510
  • [38] Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
    You, Jingjing
    Wen, Li
    Roufas, Athena
    Hodge, Chris
    Sutton, Gerard
    Madigan, Michele C.
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [39] Hepatic expression of HGF/C-met and native liver survival in biliary atresia
    Tangtrongchitr, Panicha
    Poomsawat, Sopee
    Chongsrisawat, Voranush
    Honsawek, Sittisak
    Poovorawan, Yong
    Chongpison, Yuda
    Vejchapipat, Paisarn
    PEDIATRIC SURGERY INTERNATIONAL, 2020, 36 (05) : 597 - 602
  • [40] Up-regulated expression of Ezrin and c-Met proteins are related to the metastasis and prognosis of gastric carcinomas
    Zhao, Jing
    Zhang, Xiaoxiao
    Xin, Yan
    HISTOLOGY AND HISTOPATHOLOGY, 2011, 26 (09) : 1111 - 1120